This Week in Cell

A team from the University of California, San Francisco, Stanford University, and elsewhere tallies up essential genes in the bacterial species Bacillus subtilis using a CRISPR/Cas9 interference strategy. After establishing a knockdown library targeting nearly 300 genes that are known or suspected of being essential in the bug, the researchers used CRISPR-based interference to verify essential genes, uncover potential drug targets, and gauge gene interactions and functions.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Associated Press reports that gene-edited food may soon be for sale.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.